Rapport Therapeutics, Inc. Balance Sheet
Rapport Therapeutics, Inc.'s total assets for Q1 2026 were $497.60M, a decrease of -2.89% from the previous quarter. RAPP total liabilities were $26.09M for the fiscal quarter, a -6.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.